Graduate Essay Writers
Only the finest writers are selected to be a part of our team, with each possessing specialized knowledge in specific subjects and a background in academic writing..
Order for this Paper or similar Assignment Help Service
Fill the order form in 3 easy steps - Less than 5 mins.
Posted: August 1st, 2022
NURS 6521: Advanced Pharmacology Assignment Resources
NURS 6521: Advanced Pharmacology Assignment Resources
Syllabus
Resource List
This page contains all of the resources for this course.
NURS 6521: Advanced Pharmacology Assignment Resources – Week 1
Required Readings
Rosenthal, L. D., & Burchum, J. R. (2018). Lehne’s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.
Chapter 1, “Prescriptive Authority” (pp. 1–3)
Chapter 2, “Rational Drug Selection and Prescription Writing” (pp. 5–9)
Chapter 3, “Promoting Positive Outcomes of Drug Therapy” (pp. 11–16)
Chapter 4, “Pharmacokinetics, Pharmacodynamics, and Drug Interactions” (pp. 17–40)
Chapter 5, “Adverse Drug Reactions and Medical Errors” (pp. 41–49)
Chapter 6, “Individual Variation in Drug Response” (pp. 51–56)
American Geriatrics Society 2019 Beers Criteria Update Expert Panel. (2019). American Geriatrics Society 2019 updated AGS Beers criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 67(4), 674–694. doi:10.1111/jgs.15767 American Geriatrics Society 2019 Updated AGS Beers Criteria
American Geriatrics Society 2019 updated AGS Beers criteria for potentially inappropriate medication use in older adults by American Geriatrics Society, in Journal of the American Geriatrics Society, Vol. 67/Issue 4. Copyright 2019 by Blackwell Publishing. Reprinted by permission of Blackwell Publishing via the Copyright Clearance Center.
This article is an update to the Beers Criteria, which includes lists of potentially inappropriate medications to be avoided in older adults as well as newly added criteria that lists select drugs that should be avoided or have their dose adjusted based on the individual’s kidney function and select drug-drug interactions documented to be associated with harms in older adults.
Drug Enforcement Administration. (n.d.-a). Code of federal regulations. Retrieved February 1, 2019, from https://www.deadiversion.usdoj.gov/21cfr/cfr/1300/1300_01.htm
This website outlines the code of federal regulations for prescription drugs.
Drug Enforcement Administration. (n.d.-b). Mid-level practitioners authorization by state. Retrieved May 13, 2019 from http://www.deadiversion.usdoj.gov/drugreg/practioners/index.html
This website outlines the schedules for controlled substances, including prescriptive authority for each schedule.
Drug Enforcement Administration. (2006). Practitioner’s manual.
Retrieved from http://www.deadiversion.usdoj.gov/pubs/manuals/pract/index.html
This manual is a resource for practitioners who prescribe, dispense, and administer controlled substances. It provides information on general requirements, security issues, recordkeeping, prescription requirements, and addiction treatment programs.
Drug Enforcement Administration. (n.d.-c). Registration. Retrieved February 1, 2019, from https://www.deadiversion.usdoj.gov/drugreg/index.html
This website details key aspects of drug registration.
Fowler, M. D. (2015). Guide to the code of ethics for nurses with interpretive statements: Development, interpretation, and application.
Retrieved from This article is an update to the Beers Criteria, which includes lists of medications that may not be right for older people and should be avoided, as well as newly added criteria that list certain drugs that should be avoided or have their dose changed based on the person’s kidney function and certain drug-drug interactions that have been shown to cause harm in older people.
The Drug Enforcement Agency (n.d.-a). The federal code of rules. Taken from https://www.deadiversion.usdoj.gov/21cfr/cfr/1300/1300 01.htm on February 1, 2019.
On this website, you can read about the rules that the federal government has for prescription drugs.
The Drug Enforcement Agency (n.d.-b). The state decides who can be a mid-level practitioner. Found at http://www.deadiversion.usdoj.gov/drugreg/practioners/index.html on May 13, 2019.
This website tells you about the schedules for controlled substances and gives you information about who can write prescriptions for each schedule.
Practitioner’s manual, published by the Drug Enforcement Administration in 2006.
Find out more at http://www.deadiversion.usdoj.gov/pubs/manuals/pract/index.html.
This book is a guide for doctors, pharmacists, and nurses who prescribe, dispense, or give controlled substances. It tells you about general requirements, security issues, keeping records, prescription requirements, and treatment programs for addiction.
The Drug Enforcement Agency (n.d.-c). Registration. Get this information from https://www.deadiversion.usdoj.gov/drugreg/index.html on February 1, 2019.
This website has information about important parts of drug registration.
Fowler, M. D. (2015). Guide to the code of ethics for nurses with statements about how it was made, how it should be interpreted, and how it should be used.
Get this from
https://eds-b-ebscohost-com.ezp.waldenulibrary.org/eds/ebookviewer/ebook/bmxlYmtfXzEwMjE3NjNfX0FO0?sid=8cf8b6d3-6338-4e98-8254-2cadb5d74ad5@sessionmgr103&vid=0&format=EB&rid=1
This resource introduces the code of ethics for nurses and highlights critical aspects for ethical guideline development, interpretation, and application in practice.
Institute for Safe Medication Practices. (2017). List of error-prone abbreviations, symbols, and dose designations. Retrieved from https://www.ismp.org/recommendations/error-prone-abbreviations-list
This website provides a list of prescription-writing abbreviations that might lead to misinterpretation, as well as suggestions for preventing resulting errors.
Ladd, E., & Hoyt, A. (2016). Shedding light on nurse practitioner prescribing. The Journal for Nurse Practitioners, 12(3), 166–173. doi:10.1016/j.nurpra.2015.09.17
Note: You will access this article from the Walden Library databases.
This article provides NPs with information regarding state-based laws for NP prescribing.
Sabatino, J. A., Pruchnicki, M. C., Sevin, A. M., Barker, E., Green, C. G., & Porter, K. (2017). Improving prescribing practices: A pharmacist‐led educational intervention for nurse practitioner students. Journal of the American Association of Nurse Practitioners, 29(5), 248–254. doi:10.1002/2327-6924.12446
Note: You will access this article from the Walden Library databases.
The authors of this article assess the impact of a pharmacist‐led educational intervention on family nurse practitioner (FNP) students’ prescribing skills, perception of preparedness to prescribe, and perception of pharmacist as collaborator.
Required Media
Introduction to Advanced Pharmacology
Meet Dr. Terry Buttaro, associate professor of practice at Simmons School of Nursing and Health Sciences as she discusses the importance of pharmacology for the advanced practice nurse. (8m)
Accessible player –Downloads–Download Video w/CCDownload AudioDownload Transcript Introduction to Advanced Pharmacology
ORDER NOW FOR AN ORIGINAL PAPER
NURS 6521: Advanced Pharmacology Assignment Resources – Week 2
Required Readings
Rosenthal, L. D., & Burchum, J. R. (2018). Lehne’s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.
Chapter 34, “Review of Hemodynamics” (pp. 335–340)
Chapter 35, “Diuretics” (pp. 341–349)
Chapter 36, “Drugs Acting on the Renin-Angiotensin-Aldosterone System” (pp. 351–362)
Chapter 37, “Calcium Channel Blockers” (pp. 363–369)
Chapter 38, “Vasodilators” (pp. 371–373)
Chapter 39, “Drugs for Hypertension” (pp. 375–388)
Chapter 40, “Drugs for Heart Failure” (pp. 389–402)
Chapter 41, “Antidysrhythmic Drugs” (pp. 403–418)
Chapter 42, “Prophylaxis of Atherosclerotic Cardiovascular Disease: Drugs That Help Normalize Cholesterol and Triglyceride Levels” (pp. 419–439)
Chapter 43, “Drugs for Angina Pectoris” (pp. 441–450)
Chapter 44, “Anticoagulant and Antiplatelet Drugs” (pp. 451–472)
Required Media
Cardiovascular Disorders
Meet Dr. Norbert Myslinski as he discusses ACE inhibitors, angiotensin inhibitors, beta-blockers, calcium channel blockers, and diuretics as different categories of hypertension drugs. What potential drugs might be best recommended for patients suffering from hypertension? (8m) NURS 6521: Advanced Pharmacology Resource List
Accessible player –Downloads–Download Video w/CCDownload AudioDownload Transcript Cardiovascular Disorders
NURS 6521: Advanced Pharmacology Assignment Resources – Week 3
Required Readings
Rosenthal, L. D., & Burchum, J. R. (2018). Lehne’s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.
Chapter 60, “Drugs for Asthma and Chronic Obstructive Pulmonary Disease” (pp. 673–693)
Chapter 61, “Drugs for Allergic Rhinitis, Cough, and Colds” (pp. 695–702)
Document: APA Presentation Template
National Heart Lung and Blood Institute. (2007). Expert panel report 3 (EPR3): Guidelines for the diagnosis and management of asthma. Retrieved from http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm
This web resource presents guidelines for diagnosing and managing asthma and outlines treatment recommendations for specific age groups. NURS 6521: Advanced Pharmacology Resource List
NURS 6521: Advanced Pharmacology Assignment Resources – Week 4
Required Readings
Rosenthal, L. D., & Burchum, J. R. (2018). Lehne’s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.
Chapter 62, “Drugs for Peptic Ulcer Disease” (pp. 703–714)
Chapter 63, “Laxatives” (pp. 715–722)
Chapter 64, “Other Gastrointestinal Drugs” (pp. 723–735)
Chapter 78, “Antiviral Agents I: Drugs for Non-HIV Viral Infections” (pp. 867–886)
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., . . . Sanya, A. J. (2018). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 67(1), 328–357. Retrieved from https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.29367
This article details the diagnosis and management of nonalcoholic fatty liver disease. Review this article to gain an understanding of the underlying pathophysiology as well as the suggested pharmacotherapeutics that might be recommended to treat this disorder.
NURS 6521: Advanced Pharmacology Assignment Resources – Week 5
Required Readings
Rosenthal, L. D., & Burchum, J. R. (2018). Lehne’s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.
Chapter 46, “Drugs for Diabetes Mellitus” (pp. 485–509)
Chapter 47, “Drugs for Thyroid Disorders” (pp. 511–520)
American Diabetes Association. (2018). Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetes—2018. Diabetes Care, 41(Supplement 1), S73–S85. Retrieved from http://care.diabetesjournals.org/content/41/supplement_1/s73.full-text.pdf NURS 6521: Advanced Pharmacology Resource List
This article provides guidance on pharmacologic approaches to glycemic treatment as it pertains to treating patients with diabetes. Reflect on the content of this article as you continue to examine potential drug treatments for patients with diabetes.
Document: Mid-Term Summary & Study Guide (PDF)
NURS 6521: Advanced Pharmacology Assignment Resources – Week 6
Required Readings
Rosenthal, L. D., & Burchum, J. R. (2018). Lehne’s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.
Chapter 10, “Basic Principles of Neuropharmacology” (pp. 73–77)
Chapter 11, “Physiology of the Peripheral Nervous System” (pp. 79–90)
Chapter 12, “Muscarinic Agonists and Antagonists” (pp. 91–107)
Chapter 13, “Adrenergic Agonists” (pp. 109–119)
Chapter 14, “Adrenergic Antagonists” (pp. 121–132)
Chapter 15, “Indirect-Acting Antiadrenergic Agents” (pp. 133–137)
Chapter 16, “Introduction to Nervous System Pharmacology” (pp. 139–141)
Chapter 17, “Drugs for Parkinson Disease” (pp. 143–158)
Chapter 18, “Drugs for Alzheimer Disease” (pp. 159–166)
Chapter 19, “Drugs for Epilepsy” (pp. 167–189)
Chapter 20, “Drugs for Muscle Spasm and Spasticity” (pp. 191–201)
Chapter 57, “Drug Therapy of Rheumatoid Arthritis” (pp. 629–641)
Chapter 58, “Drug Therapy of Gout” (pp. 643–651)
Chapter 59, “Drugs Affecting Calcium Levels and Bone Mineralization” (pp. 653–672)
American Academy of Family Physicians. (2019). Dementia. Retrieved from http://www.aafp.org/afp/topicModules/viewTopicModule.htm?topicModuleId=5
This website provides information relating to the diagnosis, treatment, and patient education of dementia. It also presents information on complications and special cases of dementia.
Document: Mid-Term Summary & Study Guide (PDF)
Required Media
Laureate Education (Producer). (2019b). Alzheimer’s disease [Interactive media file]. Baltimore, MD: Author.
In this interactive media piece, you will engage in a set of decisions for prescribing and recommending pharmacotherapeutics to treat Alzheimer’s disease. NURS 6521: Advanced Pharmacology Resource List
Laureate Education (Producer). (2019e). Complex regional pain disorder [Interactive media file]. Baltimore, MD: Author.
In this interactive media piece, you will engage in a set of decisions for prescribing and recommending pharmacotherapeutics to treat complex regional pain disorders.
Disorders of The Nervous System
Reflect on the comprehensive review of disorders of the nervous system and think about how you might recommend or prescribe pharmacotherapeutics to treat these disorders. (15m)
Accessible player –Downloads–Download Video w/CCDownload AudioDownload Transcript Disorders of the Nervous System
NURS 6521: Advanced Pharmacology Assignment Resources – Week 8
Required Readings
Rosenthal, L. D., & Burchum, J. R. (2018). Lehne’s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.
Chapter 24, “Antipsychotic Agents and Their Use in Schizophrenia” (pp. 231–246)
Chapter 25, “Antidepressants” (pp. 247–265)
Chapter 26, “Drugs for Bipolar Disorder” (pp. 267–274)
Chapter 27, “Sedative-Hypnotic Drugs” (pp. 275–285)
Chapter 28, “Management of Anxiety Disorders” (pp. 287–292)
Chapter 29, “Central Nervous System Stimulants and Attention-Deficit/Hyperactivity Disorder” (pp. 293–299)
Required Media
Laureate Education (Producer). (2019a). Adult geriatric depression [Interactive media file]. Baltimore, MD: Author. NURS 6521: Advanced Pharmacology Resource List
In this interactive media piece, you will engage in a set of decisions for prescribing and recommending pharmacotherapeutics to treat adult geriatric depression.
Laureate Education (Producer). (2019c). Attention deficit hyperactivity disorder [Interactive media file]. Baltimore, MD: Author.
In this interactive media piece, you will engage in a set of decisions for prescribing and recommending pharmacotherapeutics to treat attention deficit hyperactivity disorder.
Laureate Education (Producer). (2019d). Bipolar therapy [Interactive media file]. Baltimore, MD: Author.
In this interactive media piece, you will engage in a set of decisions for prescribing and recommending pharmacotherapeutics for bipolar therapy.
Laureate Education (Producer). (2019g). Generalized anxiety disorder [Interactive media file]. Baltimore, MD: Author.
In this interactive media piece, you will engage in a set of decisions for prescribing and recommending pharmacotherapeutics to treat generalized anxiety disorder.
NURS 6521: Advanced Pharmacology Assignment Resources – Week 9
Required Readings
Rosenthal, L. D., & Burchum, J. R. (2018). Lehne’s pharmacotherapeutics for advacned practice providers. St. Louis, MO: Elsevier.
Chapter 48, “Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications” (pp. 521–533) NURS 6521: Advanced Pharmacology Resource List
Chapter 49, “Birth Control” (pp. 535–547)
Chapter 50, “Androgens” (pp. 549–556)
Chapter 51, “Drugs for Erectile Dysfunction and Benign Prostatic Hyperplasia” (pp. 557–569)
Lunenfeld, B., Mskhalaya, G., Zitzmann, M., Arver, S., Kalinchenko, S., Tishova, Y., & Morgentaler, A. (2015). Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male, 18(1), 5–15. doi:10.3109/13685538.2015.1004049
Note: Retrieved from the Walden Library databases.
This article presents recommendations on the diagnosis, treatment, and monitoring of hypogonadism in men. Reflect on the concepts presented and consider how this might impact your role as an advanced practice nurse in treating men’s health disorders.
Roberts, H., & Hickey, M. (2016). Managing the menopause: An update. Maturitas, 86(2016), 53–58. https://doi.org/10.1016/j.maturitas.2016.01.007
Note: Retrieved from the Walden Library databases.
This article provides an update on treatments on Vasomotor symptoms (VMS), genito-urinary syndrome of menopause (GSM), sleep disturbance, sexual dysfunction, and mood disturbance that are common during the menopause transition.
Agency for Healthcare Research and Quality. (2014). Guide to clinical preventive services, 2014: Section 2. Recommendations for adults. Retrieved from http://www.ahrq.gov/professionals/clinicians-providers/guidelines-recommendations/guide/section2.html
This website lists various preventive services available for men and women and provides information about available screenings, tests, preventive medication, and counseling.
NURS 6521: Advanced Pharmacology Assignment Resources – Week 10
Required Readings
Rosenthal, L. D., & Burchum, J. R. (2018). Lehne’s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.
Chapter 68, “Basic Principles of Antimicrobial Therapy” (pp. 769–781)
Chapter 69, “Drugs That Weaken the Bacterial Cell Wall I: Penicillins” (pp. 783–790)
Chapter 73, “Sulfonamides and Trimethoprim” (pp. 619–826)
Chapter 74, “Drug Therapy of Urinary Tract Infections” (pp. 827–831)
Chapter 75, “Antimycobacterial Agents” (pp. 833–847)
Chapter 76, “Miscellaneous Antibacterial Drugs” (pp. 849–853)
Chapter 77, “Antifungal Agents” (pp. 855–866)
Chapter 78, “Antiviral Agents I: Drugs for Non-HIV Viral Infections” (pp. 867–886)
Chapter 80, “Drug Therapy of Sexually Transmitted Diseases” (pp. 905–911)
Montaner, J. S. G., Lima, V. D., Harrigan, P. R., Lourenço, L., Yip, B., Nosyk, B., … Kendall, P. (2014). Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: The “HIV Treatment as Prevention” experience in a Canadian setting. PLoS ONE, 9(2), e87872. Retrieved from https://doi.org/10.1371/journal.pone.0087872
This study examines HAART therapy and its sustainability and profound population-level decrease in morbidity, mortality, and HIV transmission.
Document: Final Exam Study Guide (PDF)
Required Media
Pathopharmacology: Pharmacology and Immunological Disorders: Improvements in Medications and Drug Administration
Nurse Manager, Bette Nunn discusses how technology has improved the practice of administering drugs and created new and improved drug therapies. Why is technology as well as a patient’s knowledge of their own drug history important for nursing practice? (8m)
Accessible player –Downloads–Download Video w/CCDownload AudioDownload Transcript Pharmacology and the Immunological Disorders
NURS 6521: Advanced Pharmacology Assignment Resources – Week 11
Required Readings
Rosenthal, L. D., & Burchum, J. R. (2018). Lehne’s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.
Chapter 8, “Drug Therapy in Pediatric Patients” (pp. 65—67)
Corny, J., Lebel, D., Bailey, B., & Bussieres, J. (2015). Unlicensed and off-label drug use in children before and after pediatric governmental initiatives. The Journal of Pediatric Pharmacology and Therapeutics, 20(4), 316–328.
Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557722/
This article highlights pediatric governmental initiatives to prevent unlicensed and off-label drug use in children. Review these initiatives and guidelines and how they might impact your practice as an advanced practice nurse.
Panther, S. G., Knotts, A. M., Odom-Maryon, T., Daratha, K., Woo, T., & Klein, T. A. (2017). Off-label prescribing trends for ADHD medications in very young children. The Journal of Pediatric Pharmacology and Therapeutics, 22(6), 423–429. doi:10.5863/1551-6776-22.6.423 NURS 6521: Advanced Pharmacology Resource List
Note: You will access this article from the Walden Library databases.
This study examines the frequency of off-label prescribing to children and explores factors that impact off-label prescribing. This study also examines off-label prescribing to children with ADHD.
Document: Final Exam Study Guide (PDF)
Required Media
Laureate Education (Producer). (2019i). Therapy for pediatric clients with mood disorders [Interactive media file]. Baltimore, MD: Author.
Why Seek Our Custom Writing Services
Every Student Wants Quality and That’s What We Deliver
Affordable Prices
We balance affordability with exceptional writing standards by offering student-friendly prices that are competitive and reasonable compared to other writing services.
100% Plagiarism-Free
We write all our papers from scratch thus 0% similarity index. We scan every final draft before submitting it to a customer.
How it works
When you opt to place an order with Nursing StudyBay, here is what happens:
Expert paper writers are just a few clicks away
Place an order in 3 easy steps. Takes less than 5 mins.